Total number of projects: 7
As coordinator: 1
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0.17*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 2.965.207 | 7.699.900 | 1.309.118 | 1 | 2 | |
2010 | 0 | 19.943.151 | 1.603.530 | 4 |
Total number of partners: 525
Partner loyalty:
Frequent Partner: (> 2 projects): 141
Rare Partner: 384
Frequent / Rare Partner Ratio: 0.37
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-03-01 | Integrating chemical approaches to treat pancreatic cancer: making new leads for a cure | Panacreas | coordinator | 2.965.207 | 12 |
2011-02-01 | IMplementation of quality indicators in PAlliative Care sTudy | IMPACT | participant | 2.999.900 | 13 |
2011-01-01 | Stem Cells for Relevant Efficient Extended and Normalized Toxicology | SCR&TOX | participant | 4.700.000 | 15 |
2010-12-01 | Integration of Chikungunya research | ICRES | participant | 2.999.939 | 15 |
2010-11-01 | Infectious triggers of chronic autoimmunity | INTRICATE | participant | 5.965.086 | 12 |
2010-03-01 | Enhanced Protective Immunity Against Filariasis | E PIAF | participant | 5.000.000 | 11 |
2010-03-01 | Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials | LeukoTreat | participant | 5.978.126 | 25 |